Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Skin patterns form through molecular signals and genetic factors, affecting healing and dermatology.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

No link found between Coxsackie viruses and pemphigus.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Some chemicals can permanently or temporarily remove color from skin and hair, which can be distressing and is not well-regulated in cosmetics.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Epithelial stem cells are crucial for tissue renewal and repair, and understanding them could improve treatments for damage and cancer.

IL-17-producing γδ T cells help improve bone healing.

Polymeric nanoparticles show promise for treating skin diseases.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Mouse hair follicle cells briefly grow during the early hair growth phase, showing that these cells are important for starting the hair cycle.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Macrophages help regrow hair by activating stem cells using AKT/β-catenin and TNF.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.

Advanced human skin models improve drug development and could replace animal testing.

Skin problems can be caused or worsened by physical forces and pressure on the skin.